These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6792299)

  • 1. Regrowth of Pseudomonas aeruginosa and other bacteria after the bactericidal action of carbenicillin and other beta-lactam antibiotics.
    Gwynn MN; Webb TL; Rolinson GN
    J Infect Dis; 1981 Sep; 144(3):263-9. PubMed ID: 6792299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics.
    Gwynn MN; Rolinson GN
    Infection; 1980; 8(2):73-80. PubMed ID: 6771215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the apparent regrowth of Pseudomonas aeruginosa following exposure to bactericidal concentrations of carbenicillin.
    Layte S; Harris P; Rolinson GN
    Chemotherapy; 1984; 30(1):26-30. PubMed ID: 6420118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bactericidal activities of beta-lactam antibiotics determined in agar and broth media.
    Masuda G; Yajima T; Nakamura K; Yanagishita T; Hayashi H
    J Antibiot (Tokyo); 1979 Nov; 32(11):1168-73. PubMed ID: 118959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of beta-lactamases that are markedly active against carbenicillin in the Pseudomonas aeruginosa strains isolated in a medical school hospital.
    Jouvenot M; Bonin P; Michel-Briand Y
    J Antimicrob Chemother; 1983 Nov; 12(5):451-8. PubMed ID: 6423610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regrowth in post-antibiotic period. A new approach based on the early response of the growth curve (author's transl)].
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F
    Pathol Biol (Paris); 1982 Jun; 30(6):398-404. PubMed ID: 6810284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In-vitro-effect of constant and varying concentrations of beta-lactam-antibiotics on bacteria. I. Quantitative studies on the kinetics of bactericidal effects (author's transl)].
    Neussel H
    Zentralbl Bakteriol Orig A; 1978; 242(3):375-86. PubMed ID: 371260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Minimal bactericidal concentration (MBC) of carbenicillin against clinically isolated bacteria].
    Kobayashi M
    Jpn J Antibiot; 1973 Oct; 26(5):470-4. PubMed ID: 4202620
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity of beta-lactamase in Pseudomonas aeruginosa as studied by HPLC.
    de Neeling AJ; Rutgers A; Schot CS; Stobberingh EE
    J Antimicrob Chemother; 1988 Nov; 22(5):613-21. PubMed ID: 3145265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity to carbenicillin and ticarcillin, and the beta-lactamases of Pseudomonas aeruginosa in the UK in 1978-79.
    King JD; Farmer T; Reading C; Sutherland R
    J Clin Pathol; 1980 Mar; 33(3):297-301. PubMed ID: 6769973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa.
    Williams RJ; Livermore DM; Lindridge MA; Said AA; Williams JD
    J Med Microbiol; 1984 Jun; 17(3):283-93. PubMed ID: 6327987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro experiments on the working of combinations of gentamicin and beta-lactam antibiotics against Pseudonomas aeruginosa (author's transl)].
    Ullmann U
    Immun Infekt; 1975 Apr; 3(2):79-85. PubMed ID: 810407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of strains producing plasmid determined beta-lactamases among carbenicillin resistant Pseudomonas aeruginosa.
    Tirado M; Roy C; Segura C; Reig R; Hermida M; Foz A
    J Antimicrob Chemother; 1986 Oct; 18(4):453-8. PubMed ID: 3095304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics and effects of beta-lactamases].
    Avril JL; Cayla AM; Guist'hau O; Moillo-Batt A
    Pathol Biol (Paris); 1983 Jun; 31(6):471-5. PubMed ID: 6410345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative bactericidal activity of cefsulodin and ceftazidime on Pseudomonas aeruginosa].
    Delisle-Mizon F; Lesage D; Denis C; Vergez P; Daguet GL
    Pathol Biol (Paris); 1983 May; 31(5):383-6. PubMed ID: 6413938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in suppression of regrowth and resistance despite similar initial bacterial killing for meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli.
    Bergen PJ; Bulitta JB; Sime FB; Lipman J; McGregor MJ; Millen N; Paterson DL; Kirkpatrick CMJ; Roberts JA; Landersdorfer CB
    Diagn Microbiol Infect Dis; 2018 May; 91(1):69-76. PubMed ID: 29395712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics.
    Greenwood D; Eley A
    J Infect Dis; 1982 Jan; 145(1):110-7. PubMed ID: 6459389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of logistic growth model to pharmacodynamic analysis of in vitro bactericidal kinetics.
    Yano Y; Oguma T; Nagata H; Sasaki S
    J Pharm Sci; 1998 Oct; 87(10):1177-83. PubMed ID: 9758673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regrowth of aminoglycoside-resistant variants and its possible implication for determination of MICs.
    Sörén L; Nilsson L
    Antimicrob Agents Chemother; 1984 Oct; 26(4):501-6. PubMed ID: 6440473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro comparative activity of 4 beta-lactams against Pseudomonas aeruginosa. Role of cefoperazone].
    Joly-Guillou ML; Bergogne-Berezin E; Verin-Prevost C
    Pathol Biol (Paris); 1984 May; 32(5):408-11. PubMed ID: 6429612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.